astrazeneca glp-1 launches combo to treat obesity co-morbidities AstraZeneca's elecoglipron just posted some

Can Saxenda or obesity cause shortness of breath

Its dual mechanism as a GLP-1 receptor agonist provides powerful effects on both glycemic control and body weight regulation, with efficacy that exceeds previous pharmacological approaches

Learn how stress and cortisol may affect gut health and GLP-1 signaling through SCFAs and Akkermansia

Findings from a recent study are providing support for the combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to optimize cardiovascular and kidney outcomes in patients with diabetes

This synergy of enzymes helps compensate for enzyme deficiency, a key factor in lactose and glucose intolerance

It is an exciting time for patients and providers alike, and I am hopeful these advances will continue to improve access, affordability, and long-term outcomes